47 related articles for article (PubMed ID: 29363758)
21. Thalassemia and hepatocellular carcinoma: links and risks.
Marsella M; Ricchi P
J Blood Med; 2019; 10():323-334. PubMed ID: 31572038
[TBL] [Abstract][Full Text] [Related]
22. Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations.
Rostoker G; Vaziri ND
Heliyon; 2019 Jul; 5(7):e02045. PubMed ID: 31338466
[TBL] [Abstract][Full Text] [Related]
23. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
Porter JB; Elalfy M; Taher A; Aydinok Y; Lee SH; Sutcharitchan P; El-Ali A; Han J; El-Beshlawy A
Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
[TBL] [Abstract][Full Text] [Related]
24. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
Taher AT; Porter JB; Viprakasit V; Kattamis A; Chuncharunee S; Sutcharitchan P; Siritanaratkul N; Origa R; Karakas Z; Habr D; Zhu Z; Cappellini MD
Br J Haematol; 2015 Jan; 168(2):284-90. PubMed ID: 25212456
[TBL] [Abstract][Full Text] [Related]
25. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.
Inthawong K; Charoenkwan P; Silvilairat S; Tantiworawit A; Phrommintikul A; Choeyprasert W; Natesirinilkul R; Siwasomboon C; Visrutaratna P; Srichairatanakool S; Chattipakorn N; Sanguansermsri T
Hematology; 2015 Dec; 20(10):610-7. PubMed ID: 25964094
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.
Ooi GC; Khong PL; Chan GC; Chan KN; Chan KL; Lam W; Ng I; Ha SY
Br J Haematol; 2004 Feb; 124(3):385-90. PubMed ID: 14717788
[TBL] [Abstract][Full Text] [Related]
28. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
Ricchi P; Meloni A; Spasiano A; Costantini S; Pepe A; Cinque P; Filosa A
Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
[TBL] [Abstract][Full Text] [Related]
29. Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.
Bou-Fakhredin R; Bazarbachi AH; Chaya B; Sleiman J; Cappellini MD; Taher AT
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261151
[TBL] [Abstract][Full Text] [Related]
30. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
Musallam KM; Cappellini MD; Wood JC; Taher AT
Blood Rev; 2012 Apr; 26 Suppl 1():S16-9. PubMed ID: 22631036
[TBL] [Abstract][Full Text] [Related]
31. Iron Chelation Therapy as a Modality of Management.
Aydinok Y
Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
[TBL] [Abstract][Full Text] [Related]
32. Liver iron content determination by magnetic resonance imaging.
Tziomalos K; Perifanis V
World J Gastroenterol; 2010 Apr; 16(13):1587-97. PubMed ID: 20355237
[TBL] [Abstract][Full Text] [Related]
33. Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.
Viprakasit V; Tyan P; Rodmai S; Taher AT
Orphanet J Rare Dis; 2014 Sep; 9():131. PubMed ID: 25265971
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
